Comparing the expression of integrins αvβ3, αvβ5, αvβ6, αvβ8, fibronectin and fibrinogen in human brain metastases and their corresponding primary tumors

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 12, 2013, Pages 2719-2732

  Schittenhelm, Jens ^a   Klein, Annemarie ^a   Tatagiba, Marcos S ^a   Meyermann, Richard ^a   Fend, Falko ^a   Goodman, Simon L ^b   Sipos, Bence ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MERCK KGAA   (Germany)

Author keywords

Alphav; Integrins; Metastases; Prognosis

Indexed keywords

ALPHAVBETA5 INTEGRIN; ALPHAVBETA6 INTEGRIN; FIBRINOGEN; FIBRONECTIN; INTEGRIN; INTEGRIN ALPHAVBETA8; TUMOR ANTIGEN; TUMOR MARKER; VITRONECTIN RECEPTOR;

ALPHAV; ARTICLE; BIOPSY; BRAIN TUMOR; CARCINOMA; CHEMISTRY; COMPARATIVE STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; METASTASIS; PATHOLOGY; PROGNOSIS; SKIN TUMOR;

ALPHAV; INTEGRINS; METASTASES; PROGNOSIS;

ANTIGENS, NEOPLASM; BIOPSY; BRAIN NEOPLASMS; CARCINOMA; FEMALE; FIBRINOGEN; FIBRONECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHAVBETA3; INTEGRINS; MALE; MELANOMA; PROGNOSIS; RECEPTORS, VITRONECTIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84888800048     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kleinschmidt-DeMasters BK, Lillehei KO, Breeze RE. Neoplasms involving the central nervous system in the older old. Hum Pathol 2003; 34: 1137-1147.
2. Gavrilovic IT, Posner JB. Brain metastases: epidemiology and pathophysiology. J Neurooncol 2005; 75: 5-14.
3. Ray S, Dacosta-Byfield S, Ganguli A, Bonthapally V, Teitelbaum A. Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer. J Neurooncol 2013; 114: 117-125.
4. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37: 745-51.
5. Preusser M, Capper D, Ilhan-Mutlu A, BerghoffAS, Birner P, Bartsch R, Marosi C, Zielinski C, Mehta MP, Winkler F, Wick W, von Deimling A. Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol 2013; 123: 205-222.
6. Caccavari F, Valdembri D, Sandri C, Bussolino F, Serini G. Integrin signaling and lung cancer. Cell Adh Migr 2010; 4: 124-129.
7. Hynes RO, Lively JC, McCarty JH, Taverna D, Francis SE, Hodivala-Dilke K, Xiao Q. The diverse roles of integrins and their ligands in angiogenesis. Cold Spring Harb Symp Quant Biol 2002; 67: 143-153.
8. Sheppard D. Roles of alphav integrins in vascular biology and pulmonary pathology. Curr Opin Cell Biol 2004; 16: 552-557.
9. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010; 10: 9-22
10. Bates RC Colorectal cancer progression: integrin alphavbeta6 and the epithelial-mesenchymal transition (EMT). Cell Cycle 2005; 4: 1350-1352.
11. Sipos B, Hahn D, Carceller A, Piulats J, Hedderich J, KalthoffH, Goodman SL, Kosmahl M, Klöppel G. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology 2004; 45: 226-236.
12. Goodman SL, Picard M. Integrins as therapeutic targets. Tren Pharm Sci 2012; 33: 405-412.
13. Gaertner FC, Schwaiger M, Beer AJ. Molecular imaging of αvβ3 expression in cancer patients. Q J Nucl Med Mol Imaging 2010; 54: 309-326.
14. Goodman SL, Grote JH, Wilm C. Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors. Bio Open 2012; 1: 329-340.
15. Schittenhelm J, Schwab EI, Sperveslage J, Tatagiba M, Meyermann R, Fend F, Goodman SL, Sipos B. Longitudinal Expression Analysis of αv Integrins in Human Gliomas Reveals Upregulation of Integrin αvβ3 as a Negative Prognostic Factor. J Neuropath Exp Neurol 2013; 72: 194-210.
16. Mittelbronn M, Warth A, Meyermann R, Goodman S, Weller M. Expression of integrins αvβ3 and αvβ5 and their ligands in primary and secondary central nervous system neoplasms. Histol Histopathol 2013; 28: 749-758.
17. Küsters B, Westphal JR, Smits D, Ruiter DJ, Wesseling P, Keilholz U, de Waal RM. The pattern of metastasis of human melanoma to the central nervous system is not influenced by integrin alpha(v)beta(3) expression. Int J Cancer 2001; 92: 176-180.
18. Rabb H, Barroso-Vicens E, Adams R, Pow-Sang J, Ramirez G. Alpha-V/beta-3 and alpha-V/beta-5 integrin distribution in neoplastic kidney. Am J Nephrol 1996; 16: 402-408.
19. Natali PG, Hamby CV, Felding-Habermann B, Liang B, Nicotra MR, Di Filippo F, Giannarelli D, Temponi M, Ferrone S. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions. Cancer Res 1997; 5: 1554-1560.
20. Wechsel HW, Petri E, Feil G, Nelde HJ, Bichler KH, Loesr W. Renal cell carcinoma: immunohistological investigation of expression of the integrin alpha v beta 3. Anticancer Res 1999; 19: 1529-1532.
21. Liapis H, Adler LM, Wick MR, Rader JS. Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas. Hum Pathol 1997; 28: 443-449.
22. Pontes-Junior J, Reis ST, Dall'Oglio M, Neves de Oliveira LC, Cury J, Carvalho PA, Ribeiro-Filho LA, Moreira Leite KR, Srougi M. Evaluation of the expression of integrins and cell adhesion molecules through tissue microarray in lymph node metastases of prostate cancer. J Carcinog 2009; 8: 3.
23. Enns A, Korb T, Schlüter K, Gassmann P, Spiegel HU, Senninger N, Mitjans F, Haier J. Alphavbeta5-integrins mediate early steps of metastasis formation. Eur J Cancer 2005; 41: 1065-1072.
24. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, Winkler F. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 2010; 16: 116-122.
25. Li F, Liu Y, Kan X, Li Y, Liu M, Lu JG. Elevated expression of integrin αv and β5 subunit in laryngeal squamous-cell carcinoma associated with lymphatic metastasis and angiogenesis. Pathol Res Pract 2013; 209: 105-109.
26. Fabricius EM, Wildner GP, Kruse-Boitschenko U, Hoffmeister B, Goodman SL, Raguse JD. Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas. Exp Ther Med 2011; 2: 9-19.
27. Burvenich I, Schoonooghe S, Vervoort L, Dumolyn C, Coene E, Vanwalleghem L, Van Huysse J, Praet M, Cuvelier C, Mertens N, De Vos F, Slegers G. Monoclonal antibody 14C5 targets integrin alphavbeta5. Mol Cancer Ther 2008; 7: 3771-3779.
28. Ricono JM, Huang M, Barnes LA, Lau SK, Weis SM, Schlaepfer DD, Hanks SK, Cheresh DA. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. Cancer Res 2009; 69: 1383-1391.
29. Lau SK, Shields SJ, Murphy EA, Desgrosellier JS, Anand S, Huang M, Kato S, Lim ST, Weis SM, Stupack DG, Schlaepfer DD, Cheresh DA. EGFR-mediated carcinoma cell metastasis mediated by integrin αvβ5 depends on activation of c-Src and cleavage of MUC1. PLoS One 2012; 7: e36753.
30. Roth P, Silginer M, Goodman SL, Hasenbach K, Thies S, Maurer G, Schraml P, Tabatabai G, Moch H, Tritschler I, Weller M. Integrin control of the transforming growth factor-β pathway in glioblastoma. Brain 2013; 136: 564-576.
31. Bäuerle T, Komljenovic D, Merz M, Berger MR, Goodman SL, Semmler W. Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study. Int J Cancer 2011; 128: 2453-2462.
32. Bandyopadhyay A, Raghavan S. Defining the role of integrin alphavbeta6 in cancer. Curr Drug Targets 2009; 10: 645-652.
33. Marsh D, Dickinson S, Neill GW, Marshall JF, Hart IR, Thomas GJ. alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation. Cancer Res 2008; 68: 3295-3303.
34. Yang GY, Xu KS, Pan ZQ, Zhang ZY, Mi YT, Wang JS, Chen R, Niu J. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci 2008; 99: 879-887.
35. Arihiro K, Kaneko M, Fujii S, Inai K, Yokosaki Y. Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma. Breast Cancer 2000; 7: 19-26.
36. Felding-Habermann B. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 2003; 20: 203-213.
37. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; 133: 571-573.
38. Manegold C, Vansteenkiste J, Cardenal F, Schuette W, Woll PJ, Ulsperger E, Kerber A, Eckmayr J, von Pawel J. Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer. Invest New Drugs 2013; 31: 175-182.
39. O'Day S, Pavlick A, Loquai C, Lawson D, Gutzmer R, Richards J, Schadendorf D, Thompson JA, Gonzalez R, Trefzer U, Mohr P, Ottensmeier C, Chao D, Zhong B, de Boer CJ, Uhlar C, Marshall D, Gore ME, Lang Z, Hait W, Ho P; CNTO 95 Investigators. A randomised, phase II study of intetumumab, an anti-alphav-integrin mAb, alone and with dacarbazine in stage IV melanoma. Br J Cancer 2011; 105: 346-352.